Axxcess Wealth Management LLC Boosts Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Axxcess Wealth Management LLC boosted its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 44.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 2,941 shares of the biotechnology company’s stock after purchasing an additional 904 shares during the quarter. Axxcess Wealth Management LLC’s holdings in Axon Enterprise were worth $1,748,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Public Sector Pension Investment Board increased its holdings in Axon Enterprise by 19.2% during the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock worth $1,240,000 after purchasing an additional 500 shares during the last quarter. Soros Capital Management LLC purchased a new stake in Axon Enterprise during the 3rd quarter worth approximately $630,000. Friedenthal Financial increased its holdings in Axon Enterprise by 961.7% during the 4th quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock worth $808,000 after purchasing an additional 1,231 shares during the last quarter. Principal Financial Group Inc. increased its holdings in Axon Enterprise by 33.1% during the 3rd quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock worth $54,466,000 after purchasing an additional 33,869 shares during the last quarter. Finally, XTX Topco Ltd increased its holdings in Axon Enterprise by 20.6% during the 3rd quarter. XTX Topco Ltd now owns 5,650 shares of the biotechnology company’s stock worth $2,258,000 after purchasing an additional 964 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 1,035 shares of the business’s stock in a transaction on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total transaction of $646,326.45. Following the completion of the transaction, the insider now owns 124,243 shares in the company, valued at approximately $77,586,026.21. The trade was a 0.83 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Jeri Williams sold 307 shares of the business’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now owns 1,627 shares of the company’s stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,792 shares of company stock worth $1,087,843. 5.70% of the stock is owned by company insiders.

Axon Enterprise Trading Up 5.2 %

Shares of AXON stock opened at $568.11 on Thursday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99. The stock has a fifty day moving average of $592.48 and a two-hundred day moving average of $539.47. The firm has a market capitalization of $43.53 billion, a PE ratio of 146.80, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on AXON. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Robert W. Baird boosted their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Barclays reiterated a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. Finally, The Goldman Sachs Group boosted their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus target price of $604.67.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.